Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Jun 2022. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3677096012 | Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3677097015 | Bismuth biskalcitrate 140 mg and metronidazole 125 mg and tetracycline 125 mg oral capsule | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | est un(e) (attribut) | Bismuth biskalcitrate and metronidazole and tetracycline only product in oral dose form | false | Inferred relationship | Some | ||
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Plays role | Antibacterial therapeutic role (role) | false | Inferred relationship | Some | ||
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | Metronidazole (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | biskalcitrate de bismuth | false | Inferred relationship | Some | 3 | |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | Tetracycline (substance) | false | Inferred relationship | Some | 2 | |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | est un(e) (attribut) | Product containing bismuth biskalcitrate and metronidazole and tetracycline (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | a pour principe actif (attribut) | biskalcitrate de bismuth | false | Inferred relationship | Some | ||
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | a une forme pharmaceutique (attribut) | Capsule | false | Inferred relationship | Some | ||
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | a pour principe actif (attribut) | Tetracycline (substance) | false | Inferred relationship | Some | ||
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | a pour principe actif (attribut) | Metronidazole (substance) | false | Inferred relationship | Some | ||
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | a une forme pharmaceutique (attribut) | forme orale | false | Inferred relationship | Some | ||
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | a une forme pharmaceutique (attribut) | Oral capsule | false | Inferred relationship | Some | ||
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | est un(e) (attribut) | Metronidazole-containing product in oral dose form | false | Inferred relationship | Some | ||
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | est un(e) (attribut) | Product containing tetracycline in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator unit | milligram (qualifier value) | false | Inferred relationship | Some | 1 | |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator value | un | false | Inferred relationship | Some | 1 | |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator unit (attribute) | Capsule (unit of presentation) | false | Inferred relationship | Some | 1 | |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator value (attribute) | 125 (qualifier value) | false | Inferred relationship | Some | 2 | |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator unit | milligram (qualifier value) | false | Inferred relationship | Some | 2 | |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator value | un | false | Inferred relationship | Some | 2 | |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator unit (attribute) | Capsule (unit of presentation) | false | Inferred relationship | Some | 2 | |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator value (attribute) | 125 (qualifier value) | false | Inferred relationship | Some | 3 | |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator unit | milligram (qualifier value) | false | Inferred relationship | Some | 3 | |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator value | un | false | Inferred relationship | Some | 3 | |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator unit (attribute) | Capsule (unit of presentation) | false | Inferred relationship | Some | 3 | |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | Tetracycline (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator value (attribute) | 125 (qualifier value) | false | Inferred relationship | Some | 1 | |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | biskalcitrate de bismuth | false | Inferred relationship | Some | 2 | |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator value (attribute) | 140 (qualifier value) | false | Inferred relationship | Some | 2 | |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | Metronidazole (substance) | false | Inferred relationship | Some | 3 | |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | a pour principe actif (attribut) | Metronidazole (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | Metronidazole (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | a pour principe actif (attribut) | biskalcitrate de bismuth | false | Inferred relationship | Some | 3 | |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | biskalcitrate de bismuth | false | Inferred relationship | Some | 3 | |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator value (attribute) | 140 (qualifier value) | false | Inferred relationship | Some | 3 | |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | a pour principe actif (attribut) | Tetracycline (substance) | false | Inferred relationship | Some | 2 | |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | Tetracycline (substance) | false | Inferred relationship | Some | 2 | |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Has unit of presentation | Capsule (unit of presentation) | false | Inferred relationship | Some | ||
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | Tetracycline (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | Metronidazole (substance) | false | Inferred relationship | Some | 3 | |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | biskalcitrate de bismuth | false | Inferred relationship | Some | 2 | |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | est un(e) (attribut) | Product containing bismuth biskalcitrate and metronidazole and tetracycline in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Count of base of active ingredient | trois | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set (foundation metadata concept)
FHIR